Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Patent
1995-01-20
1997-06-24
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
A61K 3554
Patent
active
056415176
DESCRIPTION:
BRIEF SUMMARY
The present invention relates to the use of fertilized shell eggs to enhance sexual potency (libido), and to compositions comprising such eggs or extracts thereof.
Human sex drive is affected by many factors, such as gender, age, stress levels, and psychological factors. Reduced sex drive affects the general physical and mental well-being of those concerned and is a cause for concern not just for the individual so afflicted but also for his or her sexual partner.
Over the ages many substances have been prepared for enhancing sex drive, but most have not been proven to have any positive effect.
Those treatments with proven success generally fall into two categories--treatment with hormones such as testosterone and treatment with vasodilatory drugs. Vasodilators have a direct physical effect, facilitating erection, rather than affecting the individual's libido or sex drive. On the other hand, with many males low sex drive correlates to low testosterone levels and in these circumstances testosterone administered by injection or transdermally has shown some success. The success however is limited to those whose testosterone level is low--testosterone therapy has not generally been found to be effective in increasing sex drive in the normal adult.
We have now found however that sex drive can be increased by administration into the gastrointestinal tract of fertilized shell eggs, i.e. reptile or avian eggs, or compositions derived therefrom.
As described further below this surprising effect has been proven in double blind clinical trials.
In these trials it has been shown that the subjects having low testosterone levels may have those levels significantly increased. Nonetheless, unlike direct testosterone therapy, the treatment enhances sex drive even in individuals with normal testosterone levels.
Thus viewed from one aspect this invention provides a method of treatment of the human or non-human mammalian body to increase libido or to enhance body testosterone levels, said method comprising administering to said body, preferably into the gastrointestinal tract thereof, e.g. rectally or more preferably orally, a therapeutic agent deriving from fertilized, incubated shell eggs.
By a shell egg is meant an animal egg (e.g. bird or reptile egg) having an opaque shell.
Particularly preferably, the eggs used will be avian eggs, especially those from birds bred for egg production, e.g. hens, geese, ducks, quail, turkeys, ostriches, pheasants, pigeons or the like, most especially hens.
As shown by the trials reported below, the libido enhancing effect occurs with fertilized and incubated eggs rather than with unfertilized and/or unincubated eggs. It is believed that this is as a result of the production of the active factors in the transformation of the egg yolk during embryogenesis.
In the general production of eggs for human consumption, the eggs used are either unfertilized or majoritively unfertilized, and even if fertilized eggs are (inadvertently) presented for human consumption these will generally be unincubated eggs or eggs which have been incubated only for 1 or 2 days.
The eggs used according to the invention are desirably ones in the blastodermal and subsequent preembryonic to protoembryonic stages in which yolk transformation has begun, but the organs of the embryo are barely if at all discernible; this corresponds essentially to the subembryonic liquid stage of embryogenesis (generally 3 to 14 days incubation for a hen's egg), or the period up to the acceleration of calcium uptake by the embryo (this occurs after about 15 days incubation for the hen's egg).
In the case of fertilized hens' eggs used according to the invention, the incubation period is preferably 2 to 15 days especially 3 to 12, particularly 5 to 10, and most preferably about 9 or about 10 days. Eggs incubated for such periods would generally not be considered fit for human consumption due to the degree of transformation of the yolk that has occurred and, for the upper limit due to the presence of an embryo with visible organs.
Viewed from a
REFERENCES:
Chemical Abs vol. 84 No. 7 41005h (16 Feb. 1976) Woods et al.
Reynolds et al "Martindale the Extra Pharmacopedia" 1989 the Pharmaceutical Press, London GB pp.1383-1384 (3874x).
Eskeland Bj.o slashed.dne
Gjendemsj.o slashed. Peder
Drymed AS
Lilling Herbert J.
LandOfFree
Composition comprising fertilized shell eggs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition comprising fertilized shell eggs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition comprising fertilized shell eggs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-147848